Log in
Enquire now

List of Sydnexis patents

List of Sydnexis patents
List of ZAF Energy Systems patents
List of Fendi patents
List of IXYS Corporation patents
List of companies in Everest Venture Capital's investment portfolio
List of companies in Venista Ventures's investment portfolio
Patents where
Current Assignee
Name
is
SydnexisSydnexis
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 10201534 Ophthalmic composition

Patent 10201534 was granted and assigned to Sydnexis on February, 2019 by the United States Patent and Trademark Office.

Sydnexis
Sydnexis
Sydnexis
Sydnexis
United States Patent and Trademark Office
United States Patent and Trademark Office
10201534
February 12, 2019
‌
US Patent 10888557 Ophthalmic composition

Patent 10888557 was granted and assigned to Sydnexis on January, 2021 by the United States Patent and Trademark Office.

Sydnexis
Sydnexis
Sydnexis
Sydnexis
United States Patent and Trademark Office
United States Patent and Trademark Office
10888557
January 12, 2021
‌
US Patent 10076515 Ophthalmic Composition

Patent 10076515 was granted and assigned to Sydnexis on September, 2018 by the United States Patent and Trademark Office.

Sydnexis
Sydnexis
Sydnexis
Sydnexis
United States Patent and Trademark Office
United States Patent and Trademark Office
10076515
September 18, 2018
‌
US Patent 10940145 Ophthalmic composition

Patent 10940145 was granted and assigned to Sydnexis on March, 2021 by the United States Patent and Trademark Office.

Sydnexis
Sydnexis
Sydnexis
Sydnexis
United States Patent and Trademark Office
United States Patent and Trademark Office
10940145
March 9, 2021
‌
US Patent 10953002 Ophthalmic composition

Patent 10953002 was granted and assigned to Sydnexis on March, 2021 by the United States Patent and Trademark Office.

Sydnexis
Sydnexis
Sydnexis
Sydnexis
United States Patent and Trademark Office
United States Patent and Trademark Office
10953002
March 23, 2021
‌
US Patent 11596625 Ophthalmic composition

Patent 11596625 was granted and assigned to Sydnexis on March, 2023 by the United States Patent and Trademark Office.

Sydnexis
Sydnexis
Sydnexis
Sydnexis
United States Patent and Trademark Office
United States Patent and Trademark Office
11596625
March 7, 2023
‌
US Patent 9421199 Ophthalmic composition

Patent 9421199 was granted and assigned to Sydnexis on August, 2016 by the United States Patent and Trademark Office.

Sydnexis
Sydnexis
Sydnexis
Sydnexis
United States Patent and Trademark Office
United States Patent and Trademark Office
9421199
August 23, 2016
‌
US Patent 9770447 Ophthalmic composition

Patent 9770447 was granted and assigned to Sydnexis on September, 2017 by the United States Patent and Trademark Office.

Sydnexis
Sydnexis
Sydnexis
Sydnexis
United States Patent and Trademark Office
United States Patent and Trademark Office
9770447
September 26, 2017
‌
US Patent 11052095 D2O stabilized pharmaceutical formulations

Patent 11052095 was granted and assigned to Sydnexis on July, 2021 by the United States Patent and Trademark Office.

Sydnexis
Sydnexis
Sydnexis
Sydnexis
United States Patent and Trademark Office
United States Patent and Trademark Office
11052095
July 6, 2021
‌
US Patent 11052094 D

Patent 11052094 was granted and assigned to Sydnexis on July, 2021 by the United States Patent and Trademark Office.

Sydnexis
Sydnexis
Sydnexis
Sydnexis
United States Patent and Trademark Office
United States Patent and Trademark Office
11052094
July 6, 2021
‌
US Patent 10813923 Ophthalmic composition

Patent 10813923 was granted and assigned to Sydnexis on October, 2020 by the United States Patent and Trademark Office.

Sydnexis
Sydnexis
Sydnexis
Sydnexis
United States Patent and Trademark Office
United States Patent and Trademark Office
10813923
October 27, 2020
‌
US Patent 10864208 Ophthalmic composition

Patent 10864208 was granted and assigned to Sydnexis on December, 2020 by the United States Patent and Trademark Office.

Sydnexis
Sydnexis
Sydnexis
Sydnexis
United States Patent and Trademark Office
United States Patent and Trademark Office
10864208
December 15, 2020
‌
US Patent 10842787 Ophthalmic composition

Patent 10842787 was granted and assigned to Sydnexis on November, 2020 by the United States Patent and Trademark Office.

Sydnexis
Sydnexis
Sydnexis
Sydnexis
United States Patent and Trademark Office
United States Patent and Trademark Office
10842787
November 24, 2020
‌
US Patent 12070466 D

Patent 12070466 was granted and assigned to Sydnexis on August, 2024 by the United States Patent and Trademark Office.

Sydnexis
Sydnexis
Sydnexis
Sydnexis
United States Patent and Trademark Office
United States Patent and Trademark Office
12070466
August 27, 2024
‌
US Patent 11890277 Ophthalmic composition

Patent 11890277 was granted and assigned to Sydnexis on February, 2024 by the United States Patent and Trademark Office.

Sydnexis
Sydnexis
Sydnexis
Sydnexis
United States Patent and Trademark Office
United States Patent and Trademark Office
11890277
February 6, 2024
‌
US Patent 11883390 Ophthalmic composition

Patent 11883390 was granted and assigned to Sydnexis on January, 2024 by the United States Patent and Trademark Office.

Sydnexis
Sydnexis
Sydnexis
Sydnexis
United States Patent and Trademark Office
United States Patent and Trademark Office
11883390
January 30, 2024
16 results
0 selected
16 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us